Skip to main content

Advertisement

SpringerLink
Log in

Increased plasma level of catestatin might be associated with poor prognosis in hemodialysis patients

  • Nephrology - Original Paper
  • Published:
International Urology and Nephrology Aims and scope Submit manuscript

Abstract

Purpose

Cardiac complication is a major cause of death in hemodialysis patients. The aim of the study was to determine the relationship between plasma catestatin level and cardiac death in those people.

Methods

A total of 330 maintenance hemodialysis patients were included. Blood samples were collected. Plasma catestatin level was detected by enzyme-linked immunosorbent assay. Fluid status of each patient was expressed by overhydration to total body weight ratio and daily diuresis. Each patient was followed-up for 36 months, unless some of them died in the follow-up period.

Results

In the follow-up period, only one hemodialysis patient was lost, 29 patients were died of cardiovascular diseases, 28 patients were died of other diseases and remaining 272 patients survived. Logistic multivariate regression analysis revealed that patients with plasma catestatin level ≥1.9 ng/ml were associated with increased cardiac death risk (RR 6.13, 95% CI 2.54, 18.45), and survival analysis also showed that cardiac death rate in patients with plasma catestatin level ≥1.9 ng/ml was elevated than that in patients with plasma catestatin level <1.9 ng/ml (P < 0.001). In addition, overhydration to total body weight ratio and daily diuresis both had significant linear correlations with plasma catestatin level (r = 0.502, P < 0.001 and r = −0.338, P < 0.001).

Conclusion

Circulating catestatin concentration might be an independent cardiac prognostic indicator in hemodialysis patients. Fluid status might be involved in the prognostic forecasting process.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Mancini A (2016) Hypotension and frequent hemodialysis: clarification requested regarding the KDOQI hemodialysis adequacy guideline 2015 update. Am J Kidney Dis 67:532

    Article  PubMed  Google Scholar 

  2. Checheriţă IA, Turcu F, Dragomirescu RF, Ciocâlteu A (2010) Chronic complications in hemodialysis: correlations with primary renal disease. Rom J Morphol Embryol 51:21–26

    PubMed  Google Scholar 

  3. Blagg CR (2001) Long-term complications in hemodialysis. Saudi J Kidney Dis Transpl 12:487–493

    CAS  PubMed  Google Scholar 

  4. Collins AJ, Foley RN, Chavers B, Gilbertson D, Herzog C, Johansen K, Kasiske B, Kutner N, Liu J, St Peter W, Guo H, Gustafson S, Heubner B, Lamb K, Li S, Li S, Peng Y, Qiu Y, Roberts T, Skeans M, Snyder J, Solid C, Thompson B, Wang C, Weinhandl E, Zaun D, Arko C, Chen SC, Daniels F, Ebben J, Frazier E, Hanzlik C, Johnson R, Sheets D, Wang X, Forrest B, Constantini E, Everson S, Eggers P, Agodoa L (2012) United States renal data system 2011 annual data report: atlas of chronic kidney disease and end-stage renal disease in the United States. Am J Kidney Dis 59(A7):e1–420

    Google Scholar 

  5. Taylor CV, Taupenot L, Mahata SK, Mahata M, Wu H, Yasothornsrikul S, Toneff T, Caporale C, Jiang Q, Parmer RJ, Hook VY, O’Connor DT (2000) Formation of the catecholamine release-inhibitory peptide catestatin from chromogranin A. Determination of proteolytic cleavage sites in hormone storage granules. J Biol Chem 275:22905–22915

    Article  CAS  PubMed  Google Scholar 

  6. Mahata SK, O’Connor DT, Mahata M, Yoo SH, Taupenot L, Wu H, Gill BM, Parmer RJ (1997) Novel autocrine feedback control of catecholamine release. A discrete chromogranin a fragment is a noncompetitive nicotinic cholinergic antagonist. J Clin Invest 100:1623–1633

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Mahata SK, Mahata M, Fung MM, O’Connor DT (2010) Catestatin: a multifunctional peptide from chromogranin A. Regul Pept 162:33–43

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Fung MM, Salem RM, Mehtani P, Thomas B, Lu CF, Perez B, Rao F, Stridsberg M, Ziegler MG, Mahata SK, O’Connor DT (2010) Direct vasoactive effects of the chromogranin A (CHGA) peptide catestatin in humans in vivo. Clin Exp Hypertens 32:278–287

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Gayen JR, Gu Y, O’Connor DT, Mahata SK (2009) Global disturbances in autonomic function yield cardiovascular instability and hypertension in the chromogranin a null mouse. Endocrinology 150:5027–5035

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Wang X, Xu S, Liang Y, Zhu D, Mi L, Wang G, Gao W (2011) Dramatic changes in catestatin are associated with hemodynamics in acute myocardial infarction. Biomarkers 16:372–377

    Article  CAS  PubMed  Google Scholar 

  11. Liu L, Ding W, Zhao F, Shi L, Pang Y, Tang C (2013) Plasma levels and potential roles of catestatin in patients with coronary heart disease. Scand Cardiovasc J 47:217–224

    Article  CAS  PubMed  Google Scholar 

  12. Pei Z, Ma D, Ji L, Zhang J, Su J, Xue W, Chen X, Wang W (2014) Usefulness of catestatin to predict malignant arrhythmia in patients with acute myocardial infarction. Peptides 55:131–135

    Article  CAS  PubMed  Google Scholar 

  13. Meng L, Wang J, Ding WH, Han P, Yang Y, Qi LT, Zhang BW (2013) Plasma catestatin level in patients with acute myocardial infarction and its correlation with ventricular remodelling. Postgrad Med J 89:193–196

    Article  PubMed  Google Scholar 

  14. Liu L, Ding W, Li R, Ye X, Zhao J, Jiang J, Meng L, Wang J, Chu S, Han X, Peng F (2013) Plasma levels and diagnostic value of catestatin in patients with heart failure. Peptides 46:20–25

    Article  CAS  PubMed  Google Scholar 

  15. Kim YJ, Jeon HJ, Kim YH, Jeon J, Ham YR, Chung S, Choi DE, Na KR, Lee KW (2015) Overhydration measured by bioimpedance analysis and the survival of patients on maintenance hemodialysis: a single-center study. Kidney Res Clin Pract 34:212–218

    Article  PubMed  PubMed Central  Google Scholar 

  16. Afaghi E, Tayebi A, Ebadi A, Sobhani V, Einollahi B, Tayebi M (2016) The effect of BCAA and ISO-WHEY oral nutritional supplements on dialysis adequacy. Nephrourol Mon 8:e34993

    Article  PubMed  PubMed Central  Google Scholar 

  17. Peng F, Chu S, Ding W, Liu L, Zhao J, Cui X, Li R, Wang J (2016) The predictive value of plasma catestatin for all-cause and cardiac deaths in chronic heart failure patients. Peptides 86:112–117

    Article  CAS  PubMed  Google Scholar 

  18. Stevens PE, Levin A (2013) Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline. Ann Intern Med 158:825–830

    Article  PubMed  Google Scholar 

  19. Hoppe K, Schwermer K, Klysz P, Radziszewska D, Sawatiuk P, Baum E, Kaczmarek J, Roszak M, Kaluzna M, Lindholm B, Pawlaczyk K, Oko A (2015) Cardiac troponin T and hydration status as prognostic markers in hemodialysis patients. Blood Purif 40:139–145

    Article  CAS  PubMed  Google Scholar 

  20. Xu W, Yu H, Li W, Gao W, Guo L, Wang G (2016) Plasma catestatin: a useful biomarker for coronary collateral development with chronic myocardial ischemia. PLoS ONE 11:e0149062

    Article  PubMed  PubMed Central  Google Scholar 

  21. Zhu D, Xie H, Wang X, Liang Y, Yu H, Gao W (2015) Correlation of plasma catestatin level and the prognosis of patients with acute myocardial infarction. PLoS ONE 10:e0122993

    Article  PubMed  PubMed Central  Google Scholar 

  22. Sardi GL, Maluenda G, Torguson R, Xue Z, Suddath WO, Kent KM, Lindsay J, Satler LF, Pichard AD, Waksman R (2012) Impact of diabetes mellitus on long-term clinical outcomes of patients on chronic hemodialysis after percutaneous coronary intervention. J Interv Cardiol 25:147–155

    Article  PubMed  Google Scholar 

  23. Fernández-Reyes MJ, Mon C, Heras M, Guevara P, Garcia MC, Sanchez R, Velasco S, Alvarez-Ude F (2004) Predictive value of troponin T levels for ischemic heart disease and mortality in patients on hemodialysis. J Nephrol 17:721–727

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Hemodialysis, Qilu Hospital, Shandong University, No. 107, Wenhuaxi Road, Jinan, 250012, Shandong, China

    Huaibin Sun, Wanhua Xian, Lina Geng, Engang Li, Zhiguo Peng & Jun Tian

Authors
  1. Huaibin Sun
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Wanhua Xian
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Lina Geng
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Engang Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Zhiguo Peng
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Jun Tian
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jun Tian.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.

Informed consent

Informed consent was obtained from all individual participants included in the study.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sun, H., Xian, W., Geng, L. et al. Increased plasma level of catestatin might be associated with poor prognosis in hemodialysis patients. Int Urol Nephrol 49, 1063–1069 (2017). https://doi.org/10.1007/s11255-017-1528-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11255-017-1528-8

Keywords

Search

Navigation